Bilibili ( ($BILI) ) has issued an announcement. On December 11, 2025, Bilibili Inc. announced changes in its issued shares, primarily through the ...
Debra MacCuaig, 38, developed an itch on her skin, which she dismissed as a reaction to detergent or moisturiser - but ...
Debra MacCuaig, 38, noticed that she had an unusual itch and seemed particularly tanned, but put this down to fake tanning ...
“Urine can turn pink from beetroot, orange from carrots, or bright yellow from B vitamins. Some medications can make it green ...
Agile Data Solutions Inc. finds that while most Filipino families plan early and stay connected, storm-induced confinement ...
Rashell and Brian Hallam welcomed their baby Axel to the world back in June, but their joy came with challenges. What started ...
Pfizer Inc. today announced detailed results from the Phase 3 HER2CLIMB-05 trial of the tyrosine kinase inhibitor TUKYSA® (tucatinib) as part of an investigational first-line maintenance treatment ...
A school assembly on organ donor awareness turned into a moving lesson on resilience, gratitude, and legacy earlier this week ...
You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.
Luxury Columnist on MSN
The future of preventative healthcare: Superpower biomarker testing
We tried out one of the most advanced baseline diagnostic panels available – here’s what we discovered about our health […] ...
Investors might want to bet on Bilibili (BILI), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...
Bilibili (BILI) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.08 per share a year ago. These figures are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback